Australia Home Infusion Therapy Market Size & Outlook

The home infusion therapy market in Australia is expected to reach a projected revenue of US$ 382.6 million by 2030. A compound annual growth rate of 8.7% is expected of Australia home infusion therapy market from 2024 to 2030.
Revenue, 2023 (US$M)
$213.9
Forecast, 2030 (US$M)
$382.6
CAGR, 2024 - 2030
8.7%
Report Coverage
Australia

Australia home infusion therapy market, 2018-2030 (US$M)

Australia

Related Markets

Australia home infusion therapy market highlights

  • The Australia home infusion therapy market generated a revenue of USD 213.9 million in 2023 and is expected to reach USD 382.6 million by 2030.
  • The Australia market is expected to grow at a CAGR of 8.7% from 2024 to 2030.
  • In terms of segment, anti-infective was the largest revenue generating application in 2023.
  • Endocrinology is the most lucrative application segment registering the fastest growth during the forecast period.


Home infusion therapy market data book summary

Market revenue in 2023USD 213.9 million
Market revenue in 2030USD 382.6 million
Growth rate8.7% (CAGR from 2023 to 2030)
Largest segmentAnti-infective
Fastest growing segmentEndocrinology
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationAnti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals
Key market players worldwideCVS Group PLC, Walgreens Boots Alliance Inc, UnitedHealth Group Inc, BrightSpring Health Services Inc, Fresenius Medical Care AG, ICU Medical Inc, B. Braun Medical, Baxter International Inc, BD, Smiths Group PLC, Terumo Corp, Caesarea Medical Electronics


Other key industry trends

  • In terms of revenue, Australia accounted for 0.6% of the global home infusion therapy market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, Japan home infusion therapy market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 2,171.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Home Infusion Therapy Market Companies

Name Profile # Employees HQ Website

Australia home infusion therapy market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to home infusion therapy market will help companies and investors design strategic landscapes.


Anti-infective was the largest segment with a revenue share of 26.79% in 2023. Horizon Databook has segmented the Australia home infusion therapy market based on anti-infective, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals covering the revenue growth of each sub-segment from 2018 to 2030.


According to World Bank Group, the country’s population aged 65 & above accounted for nearly 15.4% of the total population in 2017 and around 15.9% in 2019. Rise in geriatric population is anticipated to increase the demand for long-term and home care services, thereby fueling the market growth. Home care services are funded by the Australian government mainly under two programs Commonwealth Home Support Programmed and Home Care Packages Program. 

The former program is designed to support elderly population with daily tasks at home, while the latter is designed to support complex medical needs of patients. In addition, Medicare covers home care services such as palliative care. Such supportive funding options is anticipated to boost the market growth. Moreover, Increasing Choice in Home Care (ICHC) reforms were introduced by the Australian government in February 2017. ICHC is intended to enable patients to select homecare provider as per their needs, port unspent funds to new provider, prioritize access to home care services, and offer new levels of home care packages.

Reasons to subscribe to Australia home infusion therapy market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Australia home infusion therapy market databook

  • Our clientele includes a mix of home infusion therapy market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Australia home infusion therapy market , including forecasts for subscribers. This country databook contains high-level insights into Australia home infusion therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Australia home infusion therapy market size, by application, 2018-2030 (US$M)

Australia Home Infusion Therapy Market Outlook Share, 2023 & 2030 (US$M)

Australia home infusion therapy market size, by application, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more